Reduced Intensity AlloSCT in(CML) With Persistent Disease

NCT00531310 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG: Reduced Intensity Conditioning, Busulfan and Fludarabine

Sponsor

Columbia University